Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

2181

Actual shortage: 187 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 8 (0%)
Resolved: 1986 (91%)

Discontinuation Reports

349

To be discontinued: 20 (6%)
Discontinued: 329 (94%)
Reversed: 0 (0%)

Late reports

130 (5%)

Overdue reports

20 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2017-03-11 2017-05-23 466
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Resolved 2017-04-11 2017-05-25 6516
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2017-06-06 2017-07-17 12059
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2017-06-15 2017-07-26 12805
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2017-07-11 2017-07-27 15375
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2017-09-04 2018-07-31 20882
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2018-01-03 2018-02-12 34844
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2018-01-03 2018-03-06 34847
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2018-02-21 2018-05-01 40351
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2018-02-21 2018-08-09 40354
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2018-04-16 2018-05-14 46024
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2018-07-04 2018-12-28 54297
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2018-07-04 2018-07-17 54309
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2019-01-08 2019-02-14 71475
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2019-02-13 2019-02-21 75617
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2019-06-26 2019-08-19 87512
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2019-07-03 2019-08-19 88331
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2019-09-04 2019-10-28 92968
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2019-09-04 2019-11-11 92971
APO-DICLO 50MG TABLET (ENTERIC-COATED) Resolved 2019-10-09 2019-12-09 95861

Showing 1961 to 1980 of 2181

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-CETIRIZINE Discontinued 2018-05-31 2018-05-31 50998
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-09-07 2018-09-15 60241
APO-CYCLOSPORINE ORAL SOLUTION Discontinued 2018-09-07 2018-09-15 60408
APO-FAMOTIDINE TAB 20MG USP Discontinued 2018-09-07 2018-09-15 60477
APO-FAMOTIDINE TAB 40MG USP Discontinued 2018-09-07 2018-09-15 60480
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-LATANOPROST-TIMOP Discontinued 2018-09-07 2018-09-15 60572
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RIZATRIPTAN RPD Discontinued 2018-09-08 2019-04-02 60756
APO-SILDENAFIL R Discontinued 2018-09-08 2018-09-15 60787
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-12-21 2018-12-24 70347
APO-TIMOP Discontinued 2019-01-02 2019-01-02 70818
ACID CONTROL Discontinued 2019-01-03 2019-01-03 70906
APO-OFLOXACIN Discontinued 2019-01-03 2019-01-03 71017
APO-TIMOP GEL Discontinued 2019-01-03 2019-01-03 71020
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71029

Showing 1 to 20 of 349